Pfizer and Astellas announce extended survival data from EV-302 trial in advanced urothelial cancer
Additional follow-up from the Phase 3 study shows sustained overall survival benefit of enfortumab vedotin and pembrolizumab…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.